Search company, investor...

Revamp Medical

Founded Year


About Revamp Medical

Revamp Medical develops Doraya, a product to relieve congestion in Acute Heart Failure (AHF) patients.

Headquarters Location

5 Mefi

Netanya, 4250489,



Missing: Revamp Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Revamp Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Revamp Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Revamp Medical is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,802 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Revamp Medical Patents

Revamp Medical has filed 2 patents.

The 3 most popular patent topics include:

  • Acetylcholinesterase inhibitors
  • Amines
  • Beta blockers
patents chart

Application Date

Grant Date


Related Topics



Cardiovascular physiology, Sport bikes, Standard motorcycles, Cardiology, Circulating currencies


Application Date


Grant Date


Related Topics

Cardiovascular physiology, Sport bikes, Standard motorcycles, Cardiology, Circulating currencies



Latest Revamp Medical News

Revamp Medical Announces First Patient Enrolled in Early Feasibility Study, Evaluating Doraya Catheter for Relieving Congestion in Acute Heart Failure (AHF) Patients

Oct 18, 2022

USA - English Share this article Share this article Cardiologists at The Christ Hospital in Cincinnati, Ohio, are first in the US to begin testing Doraya as part of an EFS for AHF patients with insufficient response to diuretics NETANYA, Israel, Oct. 18, 2022 /PRNewswire/ --  Revamp Medical , a pioneering developer of a percutaneous device for the treatment of acute heart failure (AHF), today announced the enrollment of the first patient in a multi-site Early Feasibility Study (EFS), the DORAYA-HF. The proprietary catheter has been designed to enable cardiologists to improve venous hemodynamics (cardiac preload and renal afterload), aiming at improving diuretic efficacy. The Early Feasibility Study is being conducted by cardiologists at several US heart failure programs, including The Christ Hospital, an acute care hospital in Cincinnati, Ohio, and one of the world's best specialized hospitals for Cardiology. The cardiologists at The Christ Hospital are first in the US to enroll a patient to the EFS. The EFS will primarily examine the safety and performance of Doraya. The Doraya catheter is placed in the Inferior Vena Cava below the renal veins, applying partial adjustable flow for up to 12 hours. The device flow regulator mechanism is designed to temporarily reduce Central Venous Pressure and improve diuretic response in hospitalized patients with acute heart failure with insufficient response to diuretic therapy. "We are very pleased and excited to be the first site to enroll a first patient in the Doraya Early Feasibility Study," said Dr. Eugene S. Chung, MD, an Advanced Heart Failure cardiologist at The Christ Hospital in Cincinnati, OH. "We believe that the Doraya catheter may represent a promising effective treatment option for patients with acute heart failure and diuretic resistance. The elegance of this approach is that it addresses the local mechanism for diuretic resistance rather than apply the brute force of systemic drugs or dialysis." "This is an important milestone for us and for AHF patients worldwide, reflecting our efforts to improve AHF patients' response to diuretic therapy, thereby rapidly alleviate signs and symptoms of congestion," said Yael Shohat, COO of Revamp Medical. "We believe Doraya has the potential to fill this large unmet need." About Revamp Medical Revamp Medical is a pioneering developer of the Doraya catheter addressing the significant unmet clinical need for relieving congestion in acute heart failure (AHF) patients. Revamp's Doraya, is under clinical investigation and is not approved for sale. Please visit  for more information. SOURCE Revamp Medical

Revamp Medical Frequently Asked Questions (FAQ)

  • When was Revamp Medical founded?

    Revamp Medical was founded in 2016.

  • Where is Revamp Medical's headquarters?

    Revamp Medical's headquarters is located at 5 Mefi, Netanya.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.